Description

Delta-sleep-inducing peptide is a neuropeptide that affects a number of endocrine and physiological processes within the central nervous system. DSIP is of primary interest for its abilities to reduce oxidative stress, normalize myocardial contractility. It is also being studied as a potential target in the treatment of major depressive disorder.

Note: The DSIP  peptide is intended for research purposes only. This product has not been evaluated for safety or efficacy in food, drugs, medical devices, or cosmetics for humans or animals. We recommend that this product be handled by qualified professionals adhering to laboratory safety standards.